33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management

Project Title	33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Date	Friday, August 25, 2017
Description	The 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) was held August 26-30, 2017, in Montreal, Canada. More information on the conference can be found here. A variety of Sentinel-related work was featured, including a plenary session, presentations, posters, and more. These materials have been made available below.
Medical Product	Ranexa abiraterone acetate antipsychotic aripiprazole blood transfusion codeine sulfate combined oral contraceptive (COC) dipeptidyl peptidase-4 (DPP-4) inhibitor fentanyl transdermal system human papillomavirus (HPV) vaccine intravenous immune globulin (IGIV) intravenous immunoglobulin (IVIg) olanzapine oral anticoagulant oseltamivir quadrivalent human papillomavirus vaccination (HPV4) ranolazine risperidone rivaroxaban rotavirus vaccine sulfonylurea tetanus, diphtheria, pertussis (Tdap) vaccine tumor necrosis factor (TNF) alpha inhibitor zanamivir
Health Outcome	acute myocardial infarction (AMI) angioedema diabetes hypertension intussusception seizure stroke thromboembolic events (TEE) transfusion-related acute lung injury (TRALI) type 1 diabetes mellitus type 2 diabetes mellitus venous thromboembolism (VTE)
Host	International Society for Pharmacoepidemiology
Location	Plenary Medical Product and Performance Evaluation Programs Using Distributed Data Sources Podium/Oral Presentations Tumor Necrosis Factor-α Inhibitor (TNFi) Utilization Among Women with Live Birth Pregnancies Impact of ICD-10-CM Transition on Selected Cardiovascular-Related Events in the Sentinel System Identification of Name Confusion Medication Errors in the US FDA's Sentinel System Feasibility Analysis of Mortality Outcomes in the Sentinel Distributed Database Assessment of Prior Opioid Tolerance Among New Users of Fentanyl Transdermal System in FDA's Sentinel System Curating Inpatient Medication Use Data from a Hospital Network Electronic Medication Administration Record (eMAR) System: Lessons from the Sentinel System About Expanding Drug Safety Surveillance Potential Prospective Surveillance Pilot of Rivaroxaban Safety within the US Food and Drug Administration Sentinel System Randomized Clinical Trial Using FDA's Sentinel Infrastructure: An Analysis Assessing Feasibility Developing a Mother-Infant Cohort in Sentinel's PRISM Program as a Resource to Monitor the Safety of Vaccine Use During Pregnancy Protocol-Based Assessment of Thromboembolic Events (TEEs) after Intravenous Immune Globulin (IVIg) in the Sentinel Distributed Database (2006-2012) Practical Lessons Learned for Identification of Thromboembolic Events and Intravenous Immunoglobulin Exposure in the Sentinel Distributed Database Developing a Mobile App for Studies of Medication Safety Expansion of the US FDA's Sentinel System to Inpatient Blood Transfusion Data from Hospital Corporation of America: New Surveillance Options Posters Distributed Regression Analysis in a Distributed Health Data Network Dispensings of Influenza Antiviral Medications in the Sentinel System as a Source of Data for Influenza Surveillance Evaluation of Test Data in Distributed Research Networks: A Sentinel System Example Early Post-Approval Surveillance of New Molecular Entity Uptake in the Sentinel Distributed Database A Review of Methods for Propensity Score Matched Subgroup Analysis and Their Application in Peer Reviewed Research Studies Type 1 and Type 2 Diabetes Mellitus Identification Using ICD-9-CM Codes Within a Cohort of New Users of Drugs Labeled for Type 2 Diabetes Mellitus Trends of Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccination During Pregnancy in the Sentinel System Evaluation of Case-Finding Algorithm for Venous Thromboembolism Outcome Opportunities for Rapid Monitoring of New Cancer Treatments: Tyrosine Kinase Inhibitors in the Sentinel Distributed Database Assessment of Transfusion-Related Acute Lung Injury After Red Blood Cell, Plasma and Platelet Administration: Initial Results in the Sentinel System Symposia Integrating Sentinel into Routine Regulatory Drug Review: A Snapshot of the First Year Listening to Patient Voices in Pharmacoepidemiological Research - Opportunities for Innovation and Inclusion Promises and Challenges of Screening for Adverse Events in Sentinel Workshop TreeScan™: A Novel Data-Mining Tool for Medical Product Safety Surveillance Pre-Conference Course Using the Self-Controlled Risk Interval (SCRI) Method to Study Vaccine Safety
Event Type	Conference

Search form

News & Events

33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management